Predicting vedolizumab success with ultrasound in early Crohn's
Part of Digestive system clinical trials.
This study uses intestinal ultrasound to see if vedolizumab can heal the gut in people recently diagnosed with Crohn's disease. It aims to find early signs that the treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You were diagnosed with Crohn's disease within the past 18 months.
- You have not yet taken advanced treatments like biologics (e.g., vedolizumab).
- You have no complications like fistulas, strictures, or a history of bowel surgery.
- You plan to start vedolizumab within one month of a baseline ultrasound and endoscopy.
- You agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a medication called Guselkumab can help people with moderate to severe Crohn's disease. It uses a special ultrasound to see how the bowel responds to treatment.
This study uses ultrasound to measure how much damage Crohn's disease has caused in your intestines, which may help doctors track the disease without repeated scans or procedures.
This study uses an intestinal ultrasound (a safe, painless scan) to check how well Crohn's disease is controlled. It may help doctors see inflammation without more invasive tests.
This study tests whether a medicine called vedolizumab can help heal all layers of the bowel wall in Crohn's disease. It uses a special ultrasound to see inside the bowel, aiming for deeper healing than usual.
This study tests a medication called vedolizumab for people with moderate to severe ulcerative colitis or Crohn's disease. The goal is to see how well it works in a regular community setting, and it may help control symptoms if other treatments haven't worked.
This study looks at how ultrasound imaging of the intestine and fat can help predict if biologic therapy will work for people with ulcerative colitis. It aims to find early signs that show which patients respond best to treatment.
Hear when a new Intestinal Ultrasound trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.